| Autoantibodies against type I IFNs in patients with life-threatening COVID-19 P Bastard, LB Rosen, Q Zhang, E Michailidis, HH Hoffmann, Y Zhang, ... Science 370 (6515), eabd4585, 2020 | 2760 | 2020 |
| Inborn errors of type I IFN immunity in patients with life-threatening COVID-19 Q Zhang, P Bastard, Z Liu, J Le Pen, M Moncada-Velez, J Chen, M Ogishi, ... Science 370 (6515), eabd4570, 2020 | 2366 | 2020 |
| Monkeypox Virus Infection in Humans across 16 Countries — April–June 2022 JP Thornhill, S Barkati, S Walmsley, J Rockstroh, A Antinori, LB Harrison, ... N Engl J Med 387, 679-691, 2022 | 1964 | 2022 |
| Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study NM Kuderer, TK Choueiri, DP Shah, Y Shyr, SM Rubinstein, DR Rivera, ... The Lancet 395 (10241), 1907-1918, 2020 | 1963 | 2020 |
| Anti-tumour necrosis factor agents and tuberculosis risk: mechanisms of action and clinical management MA Gardam, EC Keystone, R Menzies, S Manners, E Skamene, R Long, ... The Lancet infectious diseases 3 (3), 148-155, 2003 | 1063 | 2003 |
| Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance P Koehler, M Bassetti, A Chakrabarti, SCA Chen, AL Colombo, M Hoenigl, ... The Lancet Infectious Diseases 21 (6), e149-e162, 2021 | 861 | 2021 |
| Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome AP Hsu, EP Sampaio, J Khan, KR Calvo, JE Lemieux, SY Patel, ... Blood, The Journal of the American Society of Hematology 118 (10), 2653-2655, 2011 | 707 | 2011 |
| Autoantibodies neutralizing type I IFNs are present in~ 4% of uninfected individuals over 70 years old and account for~ 20% of COVID-19 deaths P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, J Manry, ... Science immunology 6 (62), eabl4340, 2021 | 544 | 2021 |
| X-linked recessive TLR7 deficiency in~ 1% of men under 60 years old with life-threatening COVID-19 T Asano, B Boisson, F Onodi, D Matuozzo, M Moncada-Velez, ... Science immunology 6 (62), eabl4348, 2021 | 391 | 2021 |
| Autosomal dominant and sporadic monocytopenia with susceptibility to mycobacteria, fungi, papillomaviruses, and myelodysplasia DC Vinh, SY Patel, G Uzel, VL Anderson, AF Freeman, KN Olivier, ... Blood, The Journal of the American Society of Hematology 115 (8), 1519-1529, 2010 | 387 | 2010 |
| Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium P Grivas, AR Khaki, TM Wise-Draper, B French, C Hennessy, CY Hsu, ... Annals of oncology 32 (6), 787-800, 2021 | 329 | 2021 |
| COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA) L Pagano, J Salmanton-Garcia, F Marchesi, A Busca, P Corradini, ... J Hematol Oncol 14 (1), 168, 2021 | 310 | 2021 |
| A global effort to define the human genetics of protective immunity to SARS-CoV-2 infection JL Casanova, HC Su, L Abel, A Aiuti, S Almuhsen, AA Arias, P Bastard, ... Cell 181 (6), 1194-1199, 2020 | 276 | 2020 |
| Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial P Bégin, J Callum, E Jamula, R Cook, NM Heddle, A Tinmouth, MP Zeller, ... Nat Med 27 (11), 2012-2024, 2021 | 274 | 2021 |
| SLAMF7 is critical for phagocytosis of haematopoietic tumour cells via Mac-1 integrin J Chen, MC Zhong, H Guo, D Davidson, S Mishel, Y Lu, I Rhee, ... Nature 544 (7651), 493-497, 2017 | 270 | 2017 |
| Signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations and disseminated coccidioidomycosis and histoplasmosis EP Sampaio, AP Hsu, J Pechacek, HI Bax, DL Dias, ML Paulson, ... Journal of allergy and clinical immunology 131 (6), 1624-1634. e17, 2013 | 262 | 2013 |
| Linezolid: a review of safety and tolerability DC Vinh, E Rubinstein Journal of Infection 59, S59-S74, 2009 | 254 | 2009 |
| NADPH oxidase limits innate immune responses in the lungs in mice BH Segal, W Han, JJ Bushey, M Joo, Z Bhatti, J Feminella, CG Dennis, ... PloS one 5 (3), e9631, 2010 | 207 | 2010 |
| The fungal exopolysaccharide galactosaminogalactan mediates virulence by enhancing resistance to neutrophil extracellular traps MJ Lee, H Liu, BM Barker, BD Snarr, FN Gravelat, Q Al Abdallah, ... PLoS pathogens 11 (10), e1005187, 2015 | 178 | 2015 |
| The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies J Manry, P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, ... Proceedings of the National Academy of Sciences 119 (21), 2022 | 175 | 2022 |
Amy P. HsuNIAID, National Institutes of HealthEmail confirmado em terpmail.umd.eduMatthew P ChengMcGill UniversityEmail confirmado em mail.mcgill.ca
Katherine R CalvoSenior Research Physician, National Institutes of HealthEmail confirmado em nih.gov
Kenneth N OlivierClinical Professor of Medicine, University of North Carolina at Chapel HillEmail confirmado em med.unc.edu
Jean-Laurent Casanova, MD, PhDProfessor, Rockefeller University; Investigator, Howard Hughes Medical Institute; Head, St. GilesEmail confirmado em rockefeller.edu
William D. FoulkesProfessor of Oncology, Medicine, and Human Genetics. McGill UniversityEmail confirmado em mail.mcgill.ca
Luis Ostrosky-ZeichnerUT Medical SchoolEmail confirmado em uth.tmc.edu
Matteo BassettiChair Infectious Diseases Clinic, University of Genoa and San Martino HospitalEmail confirmado em unige.it
Donald SheppardMcGill UniversityEmail confirmado em mcgill.ca
Oliver CornelyUniversity of CologneEmail confirmado em uk-koeln.de
Irah KingMcGill UniversityEmail confirmado em mcgill.ca
Marcel BehrMcGill UniversityEmail confirmado em mcgill.ca
Jacques F. Meis, MDUniversity of CologneEmail confirmado em uk-koeln.de
Martin HoeniglAssociate Professor of Translational Mycology, Medical University of Graz, AustriaEmail confirmado em medunigraz.at
P. Lewis WhiteConsultant clinical scientist PHW Mycology Ref Lab, Hon Professor Cardiff UniversityEmail confirmado em wales.nhs.uk
Cornelia Lass-FlörlMedizinische Universität InnsbruckEmail confirmado em i-med.ac.at